ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Cynata Therapeutics Ltd

Cynata Therapeutics Ltd (CYP)

0.2325
-0.0075
(-3.12%)
Closed 05 January 4:00PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.2325
Bid
0.225
Offer
0.235
Volume
126,348
0.23 Day's Range 0.24
0.12 52 Week Range 0.345
Market Cap
Previous Close
0.24
Open
0.2375
Last Trade
1720
@
0.2325
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
224,011
Shares Outstanding
179,631,786
Dividend Yield
-
PE Ratio
-4.24
Earnings Per Share (EPS)
-0.05
Revenue
-
Net Profit
-9.75M

About Cynata Therapeutics Ltd

Sector
Health & Allied Services,nec
Industry
Nonwoven Fabrics
Website
Headquarters
Melbourne, Victoria, Aus
Founded
2013
Cynata Therapeutics Ltd is listed in the Health & Allied Services sector of the Australian Stock Exchange with ticker CYP. The last closing price for Cynata Therapeutics was AUD0.24. Over the last year, Cynata Therapeutics shares have traded in a share price range of AUD 0.12 to AUD 0.345.

Cynata Therapeutics currently has 179,631,786 shares in issue. The market capitalisation of Cynata Therapeutics is AUD43.11 million. Cynata Therapeutics has a price to earnings ratio (PE ratio) of -4.24.

CYP Latest News

FDA Meeting Provides Clear Path for Cynata US Development Plans

Cynata Pre-IND meeting with the US FDA completed successfullyFDA confirms Cymerus™ manufacturing dossier meets expectationsClear path determined for preclinical and clinical protocol...

Cynata Therapeutics Files New Patent Application for Cymerus™ Stem Cell Technology in Oncology

Application filed with IP Australia would expand patent estate to immunotherapyCreates new opportunities in the growing field of immunotherapy and reinforces a position in oncology MELBOURNE...

How to identify a medical stock offering blockbluster returns: Part 3

http://www.fool.com.au/2015/04/13/how-to-identify-a-medical-stock-offering-blockbluster-returns-part-3/

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.022510.71428571430.210.2550.213082640.2301488DE
40.00753.333333333330.2250.2550.175899860.20068271DE
12-0.0275-10.57692307690.260.260.172240110.20735052DE
26-0.0625-21.1864406780.2950.2950.171489240.21474055DE
520.102578.84615384620.130.3450.121480700.21457047DE
156-0.3125-57.33944954130.5450.60.1051129840.2315471DE
260-0.8075-77.64423076921.041.30.1051567030.50362DE

CYP - Frequently Asked Questions (FAQ)

What is the current Cynata Therapeutics share price?
The current share price of Cynata Therapeutics is AUD 0.2325
How many Cynata Therapeutics shares are in issue?
Cynata Therapeutics has 179,631,786 shares in issue
What is the market cap of Cynata Therapeutics?
The market capitalisation of Cynata Therapeutics is AUD 43.11M
What is the 1 year trading range for Cynata Therapeutics share price?
Cynata Therapeutics has traded in the range of AUD 0.12 to AUD 0.345 during the past year
What is the PE ratio of Cynata Therapeutics?
The price to earnings ratio of Cynata Therapeutics is -4.24
What is the reporting currency for Cynata Therapeutics?
Cynata Therapeutics reports financial results in AUD
What is the latest annual profit for Cynata Therapeutics?
The latest annual profit of Cynata Therapeutics is AUD -9.75M
What is the registered address of Cynata Therapeutics?
The registered address for Cynata Therapeutics is LEVEL 3, 62 LYGON STREET, CARLTON, VICTORIA, MELBOURNE, VICTORIA, 3053
What is the Cynata Therapeutics website address?
The website address for Cynata Therapeutics is www.cynata.com
Which industry sector does Cynata Therapeutics operate in?
Cynata Therapeutics operates in the NONWOVEN FABRICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
IBGIronbark Zinc Limited
AUD 0.255
(8,400.00%)
113.37k
KATOKatana Capital
AUD 0.003
(200.00%)
77.1k
TTMOTitan Minerals Limited
AUD 0.03
(87.50%)
12.33k
EELENRG Elements Ltd
AUD 0.0015
(50.00%)
10M
CCOOAThe Calmer Co International Ltd
AUD 0.0015
(50.00%)
2.21M
NRZONeuRizer Ltd
AUD 0.001
(-50.00%)
1.01M
EATEntertainment Rewards Ltd
AUD 0.002
(-50.00%)
968.35k
NACONAOS Ex50 Opportunities Company Limited
AUD 0.002
(-33.33%)
13.37k
PNTOAPanther Metals Ltd
AUD 0.002
(-33.33%)
47k
KNBOKoonenberry gold Ltd
AUD 0.005
(-28.57%)
1.63M
GCMGreen Critical Minerals Ltd
AUD 0.019
(5.56%)
117.1M
ROGRed Sky Energy Limited
AUD 0.009
(-14.29%)
74.61M
IMUImugene Limited
AUD 0.039
(4.00%)
46.15M
BRNBrainchip Holdings Ltd
AUD 0.415
(-4.05%)
35.04M
TMGTrigg Minerals Ltd
AUD 0.045
(4.65%)
28.2M

Discussion

View Full Feed
Mr. Bill Mr. Bill 4 minutes ago
https://www.medicinenet.com/what_are_blood_oxygen_levels/article.htm
devil dog 96 devil dog 96 5 minutes ago
Tell everyone why you think they never took the 39 million shares off restriction if they need shares to dump? Why have they not taken 1 share off restriction since early 2021 if they need shares to dump?? Why would they issue new shares that will be unregistered and also have to wait a year before
ATMH
CrossFireTrader CrossFireTrader 5 minutes ago
Page 22 of 26, and If say I'm Bullish that'll set 280e off, and I'll  be accused of pumping our little lottery ticket. I'm here for the long haul. I'm not here to sell at 0.016 or 0.02 or 0.03 or whatever his new price is. He actually likes GDVM a lot more than he lets on. Since you seem to be somew
GDVM
Mr. Bill Mr. Bill 9 minutes ago
https://measuringmyhealth.com/what-is-a-normal-pi-on-a-pulse-oximeter/
georgejjl georgejjl 9 minutes ago
That is WRONG. The current standard of care is donepezil (Aricept) and memantine, etc.

MAB's still are an extremely small number of treatments for Alzheimer's in the USA and worldwide.

Good luck and GOD bless,
AVXL
axelvento axelvento 29 minutes ago
Q1 the first interim analysis of the vaccine’s efficacy is expected

Moderna’s mRNA-1647
Cytomegalovirus
MRNA
MightyX MightyX 32 minutes ago
Yet no one is innocent
TPTW
BIG D 4 BIG D 4 33 minutes ago
WOW !! HAPPY NEW YEAR TO ALL THE LONGS HERE !! I HAVE 2 NAYSAYERS ON IGNORE SO I NEVER READ THEIR BS !! GO SAVING GRACE-- JJ AND ALL THE NEW POSTERS WHO ARE POSITIVE !! .02 CENTS TO START THE RUN TO ONE DOLLAR IS WHERE WE SHOULD BE !! THIS STOCK IS SUCH A GREAT BUY HERE !! I AM LOADED WITH 32 MILLI
MJNA
MightyX MightyX 33 minutes ago
The judicial system legitimizes prosecution
TPTW
jondoeuk jondoeuk 34 minutes ago
A new paper. From it: 'BNT221 was well tolerated across both DLs, with no dose-limiting toxicities of grade 3 or higher attributed to the T cell product observed. Specifically, no cytokine release, immune effector cell-associated neurotoxicity or macrophage activation syndromes were reported. A dose
BNTX
benz280c benz280c 36 minutes ago
Nice to see you are bullish. This quote may round out your knowledge.
"It is worthy to note that a new CUSIP has been approved by the CUSIP Global Services (CGS).
Subsequently, we have submitted a corporation action with FINRA for a Company name change, Ticker Symbol Change and Cusip
GDVM
shajandr shajandr 37 minutes ago
Sorry to read that you're still feeling sick. I posted a week or two ago about 41 bunnies and also some cats and dogs that were rescued from a home in Delaware county, Iowa and that were transferred to the DBQ county animal shelter. I just spoke with DaSqu_w and she went to the animal shelter to see
Lakota-45 Lakota-45 38 minutes ago
Will do, but I doubt they will listen !!!

~ Lol !!!
IONI
boi568 boi568 39 minutes ago
Probably
AVXL
HokieHead HokieHead 41 minutes ago
Wrong..
TWOH
HokieHead HokieHead 41 minutes ago
Get your facts straight, the halt was in the Canadian side as they are reviewing all the disclosures submitted, there’s ZERO issues in the US, it’s a fully reporting SEC company.
TWOH
Lakota-45 Lakota-45 43 minutes ago
I agree with you 'farmI1234 !!!

I'm pretty sure most of the Savvy Investors, that have been paying attention,
have been loading the dips, and .0004's, for a while now.
I know I have, along with fishing down stream.

I doubt any Longs will get caught short,
WDLF
CaptHowdy CaptHowdy 44 minutes ago
RECOMMENDED.... nothing is offical yet, unnecessary twisting of facts to bolster your negative viewpoints. Thats news is two months old
GRLT
axelvento axelvento 44 minutes ago
Cancer vaccines: What’s ahead in 2025

The spotlight is on mRNA-4157 (V940)

https://gulfnews.com/special-reports/cancer-vaccines-whats-ahead-in-2025-1.500010233
MRNA
facts_matter14 facts_matter14 45 minutes ago
Does this sound like a company with 16 products and a 17th on the way?

https://investorshub.advfn.com/uimage/uploads/2024/12/24/mwowsIMG_6034.png








.
SRMX
HomerRomer HomerRomer 46 minutes ago
More testimony videos from trial participants like the Australian news reel of Ern Heaven would be amazing. I would think that most of the people involved 9 years ago in the earlier phase studies have passed on since the average life expectancy is normally between 3-11 years after being diagnosed w
AVXL
CaptHowdy CaptHowdy 47 minutes ago
That's how to make money on the OTC. 🤦🏻‍♂️ Anyone could do it; only if the effort spent discounting the new leadership in place along with the turn around story underway was used to turn a profit vs. using 9yr old DD to bad mouth new CEO.
GRLT
crescentmotor crescentmotor 47 minutes ago
I think that is a bad precedent to start.

100% on parading a handful of Blarcamesine patients at the JPM conference. I highly doubt AVXL would involve itself with anecdotal gimmicks where there is no way possible to extrapolate isolated successes to meaningful conclusions about broad
AVXL JPM